Outcomes

The evidence for oxandrolone's measurable clinical outcomes comes primarily from preclinical studies and small clinical trials, with limited high-quality human data available.

Growth and Development Outcomes

In pediatric populations, oxandrolone shows potential benefits for growth parameters:

Turner syndrome: A completed Phase 2 trial (NCT00001343) examined hormonal effects in growth hormone-treated girls, though specific outcome measures are not detailed in the available evidence
Constitutional delay of growth and puberty: A 2026 meta-analysis of retrospective cohort studies examined effects on final adult height in boys, suggesting potential growth benefits, though the strength of this evidence is limited by the retrospective design

Bone Health and Recovery

Preclinical evidence suggests mixed results for bone-related outcomes:

A 2026 mouse study directly compared oxandrolone to bisphosphonates for burn-induced bone loss, providing comparative data on bone recovery, though translation to human outcomes remains uncertain
The evidence base for bone health outcomes in humans is limited

Muscle Function and Strength

Clinical trials have investigated oxandrolone's effects on muscle function in specific populations:

Facioscapulohumeral dystrophy: A completed trial (NCT00027391) combined oxandrolone with albuterol, though specific functional outcomes are not detailed
Spinal cord injury: A completed trial (NCT00223769) examined functional improvement, but outcome data is not available
Rotator cuff injury: One trial (NCT03091075) was terminated, providing no outcome data

Hematologic Outcomes

Fanconi anemia: A completed Phase 1 trial (NCT00243399) investigated oxandrolone for bone marrow aplasia, though specific hematologic response rates or improvements are not reported in the available evidence

Strength of Evidence Limitations

The current evidence base has significant limitations:

Most completed trials lack publicly available outcome data
Preclinical studies may not translate directly to human clinical benefits
Meta-analyses are limited to retrospective cohort studies rather than randomized controlled trials
One relevant trial was terminated, reducing the available evidence

The measurable outcomes for oxandrolone remain incompletely characterized in the available literature, with most specific quantitative results not reported in the accessible evidence.

This information is for educational purposes only and should not replace professional medical advice. Consult healthcare providers for treatment decisions.

Oxandrolone

Member access required